These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39105766)

  • 1. Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules:
    Kamel YN; El-Marakby EM; Gad HA
    Pharm Dev Technol; 2024 Sep; 29(7):738-750. PubMed ID: 39105766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery:
    Abdel-Rashid RS; Helal DA; Alaa-Eldin AA; Abdel-Monem R
    Drug Deliv; 2022 Dec; 29(1):294-304. PubMed ID: 35037528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
    Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
    Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efavirenz oral delivery via lipid nanocapsules: formulation, optimisation, and ex-vivo gut permeation study.
    Varshosaz J; Taymouri S; Jahanian-Najafabadi A; Alizadeh A
    IET Nanobiotechnol; 2018 Sep; 12(6):795-806. PubMed ID: 30104454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and Characterization of Puerarin-Loaded Lipid Nanocapsules.
    Zhai Y; Liu M; Wan M; Li Y; Zhang M; Zhai G
    J Nanosci Nanotechnol; 2015 Apr; 15(4):2643-9. PubMed ID: 26353476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.
    Radwan SE; Sokar MS; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2017 Jun; 526(1-2):366-379. PubMed ID: 28487189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
    Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
    Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study.
    Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT
    Drug Deliv Transl Res; 2024 Sep; 14(9):2539-2557. PubMed ID: 38376620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration.
    Paese K; Ortiz M; Frank LA; Külkamp-Guerreiro IC; Rolim CM; Barros DM; Pohlmann AR; Guterres SS
    AAPS PharmSciTech; 2017 Jan; 18(1):212-223. PubMed ID: 26956145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trazodone Loaded Lipid Core Poly (ε-caprolactone) Nanocapsules: Development, Characterization and in Vivo Antidepressant Effect Evaluation.
    Elhesaisy N; Swidan S
    Sci Rep; 2020 Feb; 10(1):1964. PubMed ID: 32029776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal lipid nanocapsules for systemic delivery of nimodipine into the brain: In vitro optimization and in vivo pharmacokinetic study.
    Mohsen K; Azzazy HME; Allam NK; Basalious EB
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111236. PubMed ID: 32806316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential
    Amara RO; Ramadan AA; El-Moslemany RM; Eissa MM; El-Azzouni MZ; El-Khordagui LK
    Int J Nanomedicine; 2018; 13():4493-4505. PubMed ID: 30122922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
    Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
    Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
    Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
    J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
    [No Abstract]   [Full Text] [Related]  

  • 16. Design and Optimization of Cationic Nanocapsules for Topical Delivery of Tretinoin: Application of the Box-Behnken Design,
    Ebrahimi S; Mahjub R; Haddadi R; Vafaei SY
    Biomed Res Int; 2021; 2021():4603545. PubMed ID: 34934769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination study of intact lipid nanocapsules after intravenous rat administration.
    Lebreton V; Legeay S; Rapenne C; Saulnier P; Lagarce F
    Nanomedicine (Lond); 2024; 19(13):1123-1131. PubMed ID: 38690778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer properties of lipid and poly(ε-caprolactone) nanocapsules loaded with ferrocenyl-tamoxifen derivatives.
    Najlaoui F; Pigeon P; Aroui S; Pezet M; Sancey L; Marrakchi N; Rhouma A; Jaouen G; De Waard M; Busser B; Gibaud S
    J Pharm Pharmacol; 2018 Nov; 70(11):1474-1484. PubMed ID: 30141195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oral bioavailability of Tanshinone IIA using lipid nanocapsules: Formulation, in-vitro appraisal and pharmacokinetics.
    Ashour AA; Ramadan AA; Abdelmonsif DA; El-Kamel AH
    Int J Pharm; 2020 Aug; 586():119598. PubMed ID: 32629068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.
    de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC
    AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.